Low Volume Nose Resistance Breathing Exercise With Incentive Spirometer in Patient With Cervical Spinal Cord Injuries
Effect of Low Volume Nose Resistance Breathing Exercise With Incentive Spirometer on Pulmonary Function Test, Dyspnea, Cough and Sputum in Patient With Cervical Spinal Cord Injuries
1 other identifier
interventional
42
1 country
1
Brief Summary
This randomized clinical trial aims to evaluate the effectiveness of combining Low Volume Nose Resistance Breathing Exercises (LVNRBE) with Incentive Spirometry (IS) on respiratory outcomes in patients with cervical spinal cord injury (SCI). Respiratory complications are a major concern in cervical SCI due to impaired respiratory muscle function, leading to reduced lung volumes, dyspnea, ineffective cough, and sputum retention. The study will recruit 42 inpatients aged 18-38 years with cervical SCI (C4-C7), randomly divided into two groups: Data Analysis: Statistical tests (paired and independent t-tests) will determine intra- and intergroup differences using SPSS v25, with significance set at p \< 0.05.
- Group A (Intervention): Receives LVNRBE using an Acapella device plus IS for 20 minutes, three times daily, five days a week for four weeks.
- Group B (Control): Receives conventional respiratory physiotherapy with the same frequency and duration. Outcomes will be assessed pre- and post-intervention using:
- Pulmonary Function Tests (FVC, FEV1),
- Modified Borg Dyspnea Scale,
- Cough Frequency Scale,
- Sputum Grading Scale.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2026
CompletedFirst Submitted
Initial submission to the registry
June 8, 2026
CompletedFirst Posted
Study publicly available on registry
June 12, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
June 12, 2026
June 1, 2026
3 months
June 8, 2026
June 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Pulmonary Function Tests (FVC, FEV1),
PFTs will be performed with Spirobank, a handheld digital spirometer, to measure respiratory parameters such as forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV ). These values help assess lung volumes, airflow, and respiratory muscle strength in spinal cord injured patients. They are highly valid and accepted internationally for assessing lung function. Test-retest reliability is strong, with correlation coefficients often exceeding 0.90.
5 weeks
Modified Borg Dyspnea Scale
The Modified Borg Scale is a validated tool used to measure perceived breathlessness.
5 weeks
Secondary Outcomes (2)
Cough Frequency Scale
5 weeks
Sputum Grading Scale.
5 weeks
Study Arms (2)
Low Volume Nose Resistance Breathing Exercises (LVNRBE)
EXPERIMENTALReceives LVNRBE using an Acapella device plus IS for 20 minutes, three times daily, five days a week for four weeks
conventional respiratory physiotherapy
ACTIVE COMPARATOR(Control): Receives conventional respiratory physiotherapy with the same frequency and duration.
Interventions
exercises were performed for 20 minutes three times daily, five times a week, over a period of four weeks under supervision
PFTs will be performed with Spirobank, a handheld digital spirometer, to measure respiratory parameters such as forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV ). These values help assess lung volumes, airflow, and respiratory muscle strength in spinal cord injured patients. They are highly valid and accepted internationally for assessing lung function. Test-retest reliability is strong, with correlation coefficients often exceeding 0.90
Eligibility Criteria
You may qualify if:
- Diagonosed cervical spine injury C4-C7
- Age 18-38 years
- Undergoing in-patient rehabilitation
- No previous history of severe pulmonary disease
- Disease duration \<1 year
- Ability to give informed consent
- Road Accident
You may not qualify if:
- Uncontrolled hypertension
- Other Neuromuscular disease
- Stage 3-4 pressure wound
- Clinical instability
- Traumatic Brain injury
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jinnah hoapital
Lahore, Punjab Province, 40100, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Arjumand Bano, MS
Riphah International University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 8, 2026
First Posted
June 12, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
June 12, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share